Literature DB >> 21656311

Differences between African American and White research volunteers in their attitudes, beliefs and knowledge regarding genetic testing for Alzheimer's disease.

Ibidapo Akinleye1, J Scott Roberts, Charmaine D M Royal, Erin Linnenbringer, Thomas O Obisesan, Grace-Ann Fasaye, Robert C Green.   

Abstract

Genetic susceptibility testing for common diseases is expanding, but little is known about race group differences in test perceptions. The purpose of this study was to examine differences between African Americans and Whites in knowledge, attitudes, and motivations regarding genetic susceptibility testing for Alzheimer's disease (AD). Before enrolling in an AD genetic testing research trial, 313 first-degree relatives of AD patients (20% African American; 71% female; mean age = 58 years) were surveyed regarding: (1) knowledge about genetics and AD risk; (2) concerns about developing AD; and (3) reasons for seeking testing. In comparison to Whites, African Americans were less knowledgeable about genetics and AD risk (p < .01) and less concerned about developing AD (p < .05), with lower levels of perceived disease risk (p = .04). The results suggest that African Americans and Whites differ notably in their knowledge, beliefs, and attitudes regarding genetic testing for AD. Additional research with more representative samples is needed to better understand these differences.

Entities:  

Mesh:

Year:  2011        PMID: 21656311      PMCID: PMC3223287          DOI: 10.1007/s10897-011-9377-6

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  41 in total

1.  Racial and ethnic variations in knowledge and attitudes about genetic testing.

Authors:  Eleanor Singer; Toni Antonucci; John Van Hoewyk
Journal:  Genet Test       Date:  2004

2.  The association between race and attitudes about predictive genetic testing.

Authors:  Nikki Peters; Abigail Rose; Katrina Armstrong
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-03       Impact factor: 4.254

Review 3.  Genetic testing for Alzheimer disease. Practical and ethical issues.

Authors:  A D Roses
Journal:  Arch Neurol       Date:  1997-10

4.  Keeping pace with the times--the Genetic Information Nondiscrimination Act of 2008.

Authors:  Kathy L Hudson; M K Holohan; Francis S Collins
Journal:  N Engl J Med       Date:  2008-06-19       Impact factor: 91.245

5.  Participation in genetic testing research varies by social group.

Authors:  Sharon Hensley Alford; Colleen M McBride; Robert J Reid; Eric B Larson; Andreas D Baxevanis; Lawrence C Brody
Journal:  Public Health Genomics       Date:  2010-03-18       Impact factor: 2.000

Review 6.  The clinical introduction of genetic testing for Alzheimer disease. An ethical perspective.

Authors:  S G Post; P J Whitehouse; R H Binstock; T D Bird; S K Eckert; L A Farrer; L M Fleck; A D Gaines; E T Juengst; H Karlinsky; S Miles; T H Murray; K A Quaid; N R Relkin; A D Roses; P H St George-Hyslop; G A Sachs; B Steinbock; E F Truschke; A B Zinn
Journal:  JAMA       Date:  1997-03-12       Impact factor: 56.272

7.  An inventory for measuring clinical anxiety: psychometric properties.

Authors:  A T Beck; N Epstein; G Brown; R A Steer
Journal:  J Consult Clin Psychol       Date:  1988-12

8.  Molecular genetic predictive testing for Alzheimer's disease: deliberations and preliminary recommendations.

Authors:  A Lennox; H Karlinsky; W Meschino; J A Buchanan; M E Percy; J M Berg
Journal:  Alzheimer Dis Assoc Disord       Date:  1994       Impact factor: 2.703

9.  Reasons for seeking genetic susceptibility testing among first-degree relatives of people with Alzheimer disease.

Authors:  J Scott Roberts; Susan A LaRusse; Heather Katzen; Peter J Whitehouse; Melissa Barber; Stephen G Post; Norman Relkin; Kimberly Quaid; Robert H Pietrzak; L Adrienne Cupples; Lindsay A Farrer; Tamsen Brown; Robert C Green
Journal:  Alzheimer Dis Assoc Disord       Date:  2003 Apr-Jun       Impact factor: 2.703

10.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

Authors:  L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

View more
  13 in total

1.  Development and validation of the Alzheimer's prevention beliefs measure in a multi-ethnic cohort-a behavioral theory approach.

Authors:  Alon Seifan; Christine A Ganzer; Francoise Vermeylen; Stephen Parry; Jifeng Zhu; Abigail Lyons; Richard Isaacson; Sarang Kim
Journal:  J Public Health (Oxf)       Date:  2017-12-01       Impact factor: 2.341

2.  Effects of racial and ethnic group and health literacy on responses to genomic risk information in a medically underserved population.

Authors:  Kimberly A Kaphingst; Jewel D Stafford; Lucy D'Agostino McGowan; Joann Seo; Christina R Lachance; Melody S Goodman
Journal:  Health Psychol       Date:  2015-02       Impact factor: 4.267

3.  Public perspectives about pharmacogenetic testing and managing ancillary findings.

Authors:  Susanne B Haga; Genevieve Tindall; Julianne M O'Daniel
Journal:  Genet Test Mol Biomarkers       Date:  2011-11-02

4.  Genetic Sample Provision Among National Alzheimer's Coordinating Center Participants.

Authors:  Shoshana H Bardach; Gregory A Jicha; Shama Karanth; Xuan Zhang; Erin L Abner
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

5.  Race, Genomics and Chronic Disease: What Patients with African Ancestry Have to Say.

Authors:  Carol R Horowitz; Kadija Ferryman; Rennie Negron; Tatiana Sabin; Mayra Rodriguez; Randi F Zinberg; Erwin Böttinger; Mimsie Robinson
Journal:  J Health Care Poor Underserved       Date:  2017

6.  Attitudes of African Americans toward return of results from exome and whole genome sequencing.

Authors:  Joon-Ho Yu; Julia Crouch; Seema M Jamal; Holly K Tabor; Michael J Bamshad
Journal:  Am J Med Genet A       Date:  2013-05       Impact factor: 2.802

7.  Perceptions of genetic testing and genomic medicine among drug users.

Authors:  David C Perlman; Camila Gelpí-Acosta; Samuel R Friedman; Ashly E Jordan; Holly Hagan
Journal:  Int J Drug Policy       Date:  2014-06-24

Review 8.  Prioritizing diversity in human genomics research.

Authors:  Lucia A Hindorff; Vence L Bonham; Lawrence C Brody; Margaret E C Ginoza; Carolyn M Hutter; Teri A Manolio; Eric D Green
Journal:  Nat Rev Genet       Date:  2017-11-20       Impact factor: 53.242

9.  Attitude Towards Alzheimer's Disease Among Undergraduate Students of University of the West Indies, Trinidad and Tobago.

Authors:  Joan Rawlins; Donovan A Mcgrowder; Lirmala Kampradi; Allan Ali; Travis Austin; Annalisa Beckles; Renesha Dass; Mahesh Diaram; Preenita Jahorie; Marika Mohammed; Isaac Dialsingh
Journal:  J Clin Diagn Res       Date:  2015-09-01

10.  Would you want to know? Public attitudes on early diagnostic testing for Alzheimer's disease.

Authors:  Elizabeth M Wikler; Robert J Blendon; John M Benson
Journal:  Alzheimers Res Ther       Date:  2013-09-06       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.